Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
V7-CQ
- Development stage
- Unknown
- Lead developer
- Immunitor
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
V7-CQ is a multi-ingredient prescription formulation and nutraceutical containing extracts of *Cissus quadrangularis*, *Withania somnifera* (Ashwagandha), *Moringa oleifera*, *Boswellia serrata*, and calcium citrate. Primarily developed as an adjunct therapy for chronic conditions like tuberculosis, V7-CQ is designed to address bone density loss and metabolic disturbances associated with long-term infection and treatment. The formulation works through several pathways: *Cissus quadrangularis* promotes osteoblastic activity and fracture healing by stimulating bone morphogenetic protein signaling; *Boswellia serrata* provides anti-inflammatory effects by inhibiting the 5-lipoxygenase (5-LOX) enzyme; *Withania somnifera* acts as an adaptogen to manage physiological stress; and *Moringa oleifera* serves as a source of essential micronutrients and antioxidants. Calcium citrate is included to support bone mineralization.
- Brand names
- V7-CQV-7-CQV 7-CQ
- Other names
- cissus quadrangularis + withania somnifera + moringa oleifera + boswellia serrata + calcium citrate
02
Targets
BMP2 (Bone morphogenetic protein 2)ALOX5 (Arachidonate 5-lipoxygenase)
Beyond the preview
Go deeper on V7-CQ.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on V7-CQ.